SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-048256
Filing Date
2019-08-30
Accepted
2019-08-30 16:01:29
Documents
11
Period of Report
2019-08-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-18063_18k.htm 8-K 43230
2 EX-5.1 a19-18063_1ex5d1.htm EX-5.1 17893
3 EX-10.1 a19-18063_1ex10d1.htm EX-10.1 316542
4 EX-10.2 a19-18063_1ex10d2.htm EX-10.2 24882
5 EX-10.3 a19-18063_1ex10d3.htm EX-10.3 23655
6 EX-10.4 a19-18063_1ex10d4.htm EX-10.4 23830
7 GRAPHIC g180631lgi001.jpg GRAPHIC 4193
8 GRAPHIC g180631kii001.jpg GRAPHIC 3062
9 GRAPHIC g180631kii002.jpg GRAPHIC 2217
10 GRAPHIC g180631lei001.jpg GRAPHIC 4193
11 GRAPHIC g180631lii001.jpg GRAPHIC 4193
  Complete submission text file 0001104659-19-048256.txt   476783
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37526 | Film No.: 191069552
SIC: 2834 Pharmaceutical Preparations